ASLAN Pharmaceuticals Limited
ASLN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44 | -$51 | -$32 | -$17 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$8 | $0 | -$3 | $0 |
| Stock-Based Comp. | $3 | $2 | $2 | $0 |
| Change in WC | -$3 | $9 | -$4 | -$0 |
| Other Non-Cash | $6 | $1 | $2 | $1 |
| Operating Cash Flow | -$46 | -$38 | -$34 | -$15 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$17 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $17 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $0 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $23 | $0 | $102 | $8 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $11 | $5 | $110 | $7 |
| Financing Cash Flow | $11 | $5 | $110 | $7 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$36 | -$33 | $76 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57 | $90 | $14 | $22 |
| End Cash | $21 | $57 | $90 | $14 |
| Free Cash Flow | -$46 | -$38 | -$34 | -$15 |